Please assess the completion status of the following clinical trial:

Trial Title: Decreasing Propofol Injection Pain by Pre-Treatment With Lidocaine in Pediatric Procedural Sedation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 2 months to 17 years~* patient already scheduled for procedural sedation with propofol~* sedation procedure to be performed by a sedationist from Children's Respiratory and Critical Care Specialists~Exclusion Criteria:~* patients who are not receiving deep sedation with propofol~* patients with allergy or other contraindication to lidocaine administration~* patients with central venous catheters as propofol does not burn when given centrally~* patients being premedicated with an analgesic other than nitrous oxide or 1% lidocaine~* patients weighing less than 5 kg to prevent any risk of inadvertent lidocaine overdose.

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Administration of 1ml of pre-treatment 1% lidocaine immediately prior to propofol induction.
- Normal Saline (Type: PLACEBO_COMPARATOR): Administration of 1ml of pre-treatment normal saline immediately prior to propofol induction.

Based on this trial design, predict the completion outcome and termination type (if applicable).